JIANGSU AIDEA PHARMACEUTICALJIANGSU AIDEA PHARMACEUTICALJIANGSU AIDEA PHARMACEUTICAL

JIANGSU AIDEA PHARMACEUTICAL

No trades
See on Supercharts

688488 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Jiangsu Aidea Pharmaceutical Co., Ltd. produces and sells human protein products, and carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents. The company operates through two segments: Formulated Products and Raw Materials. Its products include Folium Sennae Granules, Powdered Bacillus Tablets, Clindamycin Hydrochloride Capsules, Sodium Bicarbonate Tablets, Nitrendipine Tablets, Metronidazole Tablets, Compound Gentamycin Sulfate and Procaine Hydrochloride Sulfate Granules, Cefradine Capsules, Human Urinary Kallidinogenase, Crude Ulinastatin & Urokinase, High Purity Urokinase, Human Serum Albumin, Epidermal Growth Factor, Crude Human Epidermal Growth Factor, Beta-2 Microglobulin and Crude Beta-2 Microglobulin. Jiangsu Aidea Pharmaceutical was founded on December 15, 2009 and is headquartered in Yangzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688488 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company